Molecular pathways: Beta-adrenergic signaling in cancer

Clinical Cancer Research

Volumn 18, Issue 5, 2012, Pages 1201-1206

  Cole, Steven W ^a,b,c   Sood, Anil K ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; METALLOPROTEINASE; NORADRENALIN; VASCULOTROPIN;

ADRENERGIC SYSTEM; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BREAST CANCER; BREAST CARCINOMA; CANCER GROWTH; CANCER LOCALIZATION; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; DRUG EFFICACY; HUMAN; INTRACELLULAR SIGNALING; LEUKEMIA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; METASTASIS; NEUROMODULATION; NONHUMAN; NORADRENALIN RELEASE; OVARY CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84857774190     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-0641     Document Type: Article

References (60)

1. Weiner H. Perturbing the organism: the biology of stressful experience. Chicago: University of Chicago Press; 1992.
2. Sapolsky RM. Why zebras don't get ulcers: A guide to stress, stressrelated diseases, and coping. New York: Freeman; 1994.
3. Daly CJ,McGrath JC. Previously unsuspected widespread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action. Trends Pharmacol Sci 2011;32:219-26.
4. Baker JG, Hill SJ, Summers RJ. Evolution of β-blockers: from antianginal drugs to ligand-directed signalling. Trends Pharmacol Sci 2011;32:227-34.
5. Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem 1997;66:807-22. (Pubitemid 27274675)
6. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A 102:4459-64.
7. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 1999;283:655-61.
8. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998;396:474-7. (Pubitemid 28553318)
9. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006;6:240-8. (Pubitemid 43292567)
10. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 5:466-75.
11. Powe DG, Voss MJ, Zänker KS, Habashy HO, Green AR, Ellis IO, et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 2010;1:628-38.
12. Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol 2011;29:2635-44.
13. Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, Brown EN, Lee RT, Meric-Bernstam F, et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol 2011;29:2645-52.
14. De Giorgi V, Grazzini M, Gandini S, Benemei S, Lotti T, Marchionni N, et al. Treatment with β-blockers and reduced disease progression in patients with thick melanoma. Arch Intern Med 2011;171:779-81.
15. Lemeshow S, Sørensen HT, Phillips G, Yang EV, Antonsen S, Riis AH, et al. β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev 2011;20:2273-9.
16. Kulik GA, Hassan S, Karpova Y, Baurin V. Behavioral stress protects prostate cancer cells from apoptosis. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, Florida; Philadelphia (PA): AACR; 2011.
17. Palm D, Lang K, Niggemann B, Drell TL 4th, Masur K, Zaenker KS, et al. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer 2006;118:2744-9. (Pubitemid 43673352)
18. Hermes GL, Delgado B, Tretiakova M, Cavigelli SA, Krausz T, Conzen SD, et al. Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors. Proc Natl Acad Sci U S A 2009;106:22393-8.
19. Cao L, Liu X, Lin EJ,WangC, Choi EY, Riban V, et al. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell 2010;142:52-64.
20. Boyd AL, Salleh A, Humber B, Yee J, Tomes L, Kerr LR. Neonatal experiences differentially influence mammary gland morphology, estrogen receptor a protein levels, and carcinogenesis in BALB/c mice. Cancer Prev Res (Phila) 2010;3:1398-408.
21. Schuler LA, Auger AP. Psychosocially influenced cancer: diverse earlylife stress experiences and links to breast cancer. Cancer Prev Res (Phila) 2010;3:1365-70.
22. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 2010;70:7042-52.
23. Hasegawa H, Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res 2002;93:729-35.
24. Goldfarb Y, Sorski L, Benish M, Levi B, Melamed R, Ben-Eliyahu S. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg 2011;253:798-810.
25. Pimentel MA, Chai MG, Le CP, Cole SW, Sloan EK. Sympathetic nervous system regulation of metastasis. In: Jandial R, Hunter K, editors. Metastatic cancer: integrated organ system and biological approach. Austin, TX: Landes Bioscience; 2012.
26. Inbar S, Neeman E, Avraham R, Benish M, Rosenne E, Ben-Eliyahu S. Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS ONE 2011;6:e19246.
27. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006;12:939-44. (Pubitemid 44175146)
28. Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, et al. Stress hormones regulate interleukin-6 expression by human ovariancarcinoma cells through a Src-dependent mechanism. J Biol Chem 2007;282:29919-26. (Pubitemid 350035290)
29. Cole SW, Arevalo JM, Takahashi R, Sloan EK, Lutgendorf SK, Sood AK, et al. Computational identification of gene-social environment interaction at the human IL6 locus. Proc Natl Acad Sci U S A 2010;107:5681-6.
30. Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno- Smith M, et al. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growthandmetastasis. J BiolChem2010;285:35462-70.
31. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006;66:10357-64. (Pubitemid 44799755)
32. Chakroborty D, Sarkar C, Basu B, Dasgupta PS, Basu S. Catecholamines regulate tumor angiogenesis. Cancer Res 2009;69:3727-30.
33. LandenCNJr, LinYG, Armaiz PenaGN, DasPD, Arevalo JM, Kamat AA, et al. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res 2007;67:10389-96.
34. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 2006;12:369-75. (Pubitemid 43166123)
35. Lang K, Drell TL 4th, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 2004;112:231-8. (Pubitemid 39244363)
36. Drell TL 4th, Joseph J, Lang K, Niggemann B, Zaenker KS, Entschladen F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 2003;80:63-70. (Pubitemid 36851285)
37. Sood AK, Armaiz-Pena GN, Halder J, Nick AM, Stone RL, Hu W, et al. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest 2010;120:1515-23.
38. Sastry KS, Karpova Y, Prokopovich S, Smith AJ, Essau B, Gersappe A, et al. Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J Biol Chem 2007;282:14094-100. (Pubitemid 47100469)
39. Glasner A, Avraham R, Rosenne E, Benish M, Zmora O, Shemer S, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 2010;184: 2449-57.
40. Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 2009;15:2695-702.
41. Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, et al. A stress response pathway regulates DNA damage through b2- adrenoreceptors and β-arrestin-1. Nature 2011;477:349-53.
42. Collado-Hidalgo A, Sung C, Cole S. Adrenergic inhibition of innate antiviral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication. Brain Behav Immun 2006;20:552-63. (Pubitemid 44528951)
43. Shi M, Liu D, Duan H, Qian L, Wang L, Niu L, et al. The b2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Breast Cancer Res Treat 2011;125:351-62.
44. Gu L, Lau SK, Loera S, Somlo G, Kane SE. Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines. Clin Cancer Res 2009;15:7196-206.
45. Cakir Y, PlummerHK3rd, Tithof PK, Schuller HM. Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines. Int J Oncol 2002;21:153-7.
46. Chang M, Brown H, Collado-Hidalgo A, Arevalo J, Galic Z, Symensma T, et al. Beta-adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA. J Virol 2005;79:13538-47. (Pubitemid 41508166)
47. Lutgendorf SK, Degeest K, Dahmoush L, Farley D, Penedo F, Bender D, et al. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun 2011;25:250-5.
48. Lutgendorf SK, DeGeest K, Sung CY, Arevalo JM, Penedo F, Lucci J 3rd, et al. Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain Behav Immun 2009;23: 176-83.
49. Sloan EK, Capitanio JP, Tarara RP, Mendoza SP, Mason WA, Cole SW. Social stress enhances sympathetic innervation of primate lymph nodes: mechanisms and implications for viral pathogenesis. J Neurosci 2007;27:8857-65. (Pubitemid 47292761)
50. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007;449:721-5. (Pubitemid 47552095)
51. Cohen MJ, Shankar R, Stevenson J, Fernandez R, Gamelli RL, Jones SB. Bone marrow norepinephrine mediates development of functionally different macrophages after thermal injury and sepsis. Ann Surg 2004;240:132-41. (Pubitemid 38808245)
52. Engler H, Bailey MT, Engler A, Sheridan JF. Effects of repeated social stress on leukocyte distribution in bone marrow, peripheral blood and spleen. J Neuroimmunol 2004;148:106-15. (Pubitemid 38229563)
53. Laakko T, Fraker P. Rapid changes in the lymphopoietic and granulopoietic compartments of the marrow caused by stress levels of corticosterone. Immunology 2002;105:111-9. (Pubitemid 34128046)
54. Tang Y, Shankar R, Gamboa M, Desai S, Gamelli RL, Jones SB. Norepinephrine modulates myelopoiesis after experimental thermal injury with sepsis. Ann Surg 2001;233:266-75. (Pubitemid 32106082)
55. Cole SW. Beta-adrenergic regulation of gene expression in cancer. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, Florida; Philadelphia (PA): AACR; 2011.
56. Shah SM, Carey IM, Owen CG, Harris T, Dewilde S, Cook DG. Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br J Clin Pharmacol 2011;72:157-61.
57. Powe DG, Voss MJ, Habashy HO, Zanker KS, Green AR, Ellis IO, et al. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study. Breast Cancer Res Treat 2011;130:457-63.
58. Antoni MH, Lutgendorf SK, Blomberg B, Stagl J, Carver CS, Lechner S, et al. Transcriptional modulation of human leukocytes by cognitivebehavioral stress management in women undergoing treatment for breast cancer. Biol Psychiatry 2011 Nov 14. [Epub ahead of print].
59. Lutgendorf SK, Sood AK, Antoni MH. Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol 2010;28:4094-9.
60. Lutgendorf SK, Lamkin DM, Jennings NB, Arevalo JM, Penedo F, DeGeest K, et al. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma. Clin Cancer Res 2008;14:6839-46.